ProShare Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,558
Closed -$205K 2187
2024
Q4
$205K Buy
+1,558
New +$191K ﹤0.01% 1871
2022
Q2
Sell
-1,114
Closed -$284K 1993
2022
Q1
$284K Sell
1,114
-133
-11% -$36.1K ﹤0.01% 1663
2021
Q4
$408K Buy
1,247
+478
+62% +$150K ﹤0.01% 1591
2021
Q3
$233K Sell
769
-634
-45% -$180K ﹤0.01% 1708
2021
Q2
$380K Sell
1,403
-7
-0.5% -$1.77K ﹤0.01% 1731
2021
Q1
$343K Buy
1,410
+268
+23% +$73.7K ﹤0.01% 1717
2020
Q4
$327K Buy
+1,142
New +$314K ﹤0.01% 1556
2014
Q2
Sell
-2,694
Closed -$243K 2544
2014
Q1
$243K Buy
+2,694
New +$229K ﹤0.01% 2386

Other funds holding MLAB

ProShare Advisors's MLAB Position: Q1 2025 in Review

ProShare Advisors sold out of Mesa Laboratories (MLAB) in Q1 2025, closing a stake of 1,558 shares — an estimated $205K sold.

ProShare Advisors first reported a position in MLAB in Q1 2014 and held it in 8 quarters. The position peaked at $408K in Q4 2021. 151 funds tracked by Wall St. Rank hold MLAB as of Q1 2025.

  • ProShare Advisors reported no remaining Mesa Laboratories position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 1,558 Mesa Laboratories shares in Q1 2025, an estimated $205K.
  • ProShare Advisors first reported a position in Mesa Laboratories in Q1 2014 and held it in 8 quarters.
  • ProShare Advisors's Mesa Laboratories position peaked at $408K in Q4 2021.
  • 151 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.